Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by gottahunchon Jan 18, 2020 10:46am
149 Views
Post# 30568637

RE:Aphria is the best stop complaining

RE:Aphria is the best stop complainingVery well said, agree with all of these points. Despite these positive points, the market is still not recognizing and rewarding Aphria for them as shown by the SP. The narrative needs to change and it's up to the management team to ensure that happens. We need more PR and at least some kind of a JV. GLTA
N00bInvesT0R wrote:
Hexo
  1. They cut their guidance
  2. They cut their selling price/gram
  3. They acquired NewStrike and forgot they had no liscence in one of the rooms
  4. Sebastien St-Louis doing raising after all the damage has been done accumulating shares
  5. No profitability in the near term
Aurora Cannabis
  1. Gives a guidance for a Q report and can't even respect it
  2. Promised profitability 2019/2020 far from there
  3. Diluting all the shareholders  acquiring all sorts of companies
  4. All those acquisitions don't pay off and now they are super low on cash
  5. They are selling a greenhouse to survive
  6. All the warrants gonna expire soon hope you ready to get more diluted
  7. Drastic slowdown in sales reported last Q
  8. Insanely overvalued

Canopy Growth Corporation
  1. Solid balance sheet
  2. Horrible cost/gram
  3. Late rollout of 2.0 even with Constellation Brands expertise
  4. No profitability in sight before 2021
  5. Kicked out Bruce Linton but they spending as much if not worst
  6. At least they don't dilute shareholders like crazy and have a good revenue stream for the size they are
Canntrust
  1. Management back in the days bunch of liars
  2. Illegal rooms
  3. Liscence suspended
  4. Say no more

Then you have Aphria :
Aphria
  1. No shareholder dilution
  2. Strong balance sheet (no need for a behemoth)
  3. Assets acquired bring value (not like Aurora)
  4. Best Performer in terms of Revenue generated vs their market cap
  5. Yes guidance was revised but with the vape crisis and Ontario, reasons are legit
  6. Many awards for their brands
  7. Demand for their product so high they had to buy from another Lp to satisfy demand due to delayed delivery of Liscence by HC
  8. Number 1 selller in oils and capsules
  9. Number 3 in flowers
  10. Increase in recreational sales, for 2 quarters in a row, brand recognition is real
  11. Even if its not 100% cannabis revenues, they generating impressive revenues




Apha is beating ACB for the past 3 quarters
Apha is beating WEED since 2020


We longs should be rich already.
Sadly Aurora and Weed has a higher market cap than Aphria

You're holding the best stock in the mj sector , stop complaining



Bullboard Posts